Stop. "Barefoot in rat-infested muddy water" is not a background detail — it is the case's most important sentence. What does this exposure pattern make you reach for immediately, and why does the epidemiology matter before anything else?
Explain the epidemiology and transmission routes of Leptospira interrogans, including which occupational groups are at highest risk, and describe the classic biphasic clinical course distinguishing the leptospiraemic from the immune phase.
Occupational exposure to animal urine in flood-prone or agricultural settings is the canonical risk factor for leptospirosis. Spirochaetes enter through skin abrasions or mucous membranes — working barefoot in rat-infested water is textbook inoculation. Always ask farmers and sewer workers about waterlogged exposure.
| Epidemiology | 60/M; agric worker; tropical/subtropical setting; rat-infested water contact |
| Predisposing conditions | DM2, HTN; immunocompromise possible |
| Pathophysiology | Leptospira interrogans → systemic vasculitis → multiorgan involvement (liver, kidney, lungs, eyes) |
| Symptoms so far | 1/52 malaise, myalgia, anorexia, fever, polyuria, abdominal distension |
| Signs | Pending |
| Investigations | Pending |
| Complications | AKI, jaundice (Weil's), pulm haemorrhage, uveitis |
| Treatment | Doxycycline (mild); IV Penicillin G / Ceftriaxone (severe) |
Stop. The fever "resolved quickly" but the patient re-presents with fatigue and myalgia 4 days later. What classic disease pattern does this symptom trajectory most suggest, and how does it change your initial diagnostic frame?
Leptospirosis classically shows a "defervescence trap." The leptospiraemic phase (days 1–7) resolves spontaneously — doctors and patients are lulled into thinking recovery is underway. The immune phase (days 7–14+) then brings hepato-renal involvement. Recognise the biphasic trajectory before labs return.
Stop. He is taking Glibenclamide and Metformin. If this patient is developing AKI — which is very likely — what is the specific danger posed by each of these drugs?
Compare the risks of Metformin and Glibenclamide in a patient developing acute kidney injury, focusing on Metformin-associated lactic acidosis and sulphonylurea-induced hypoglycaemia. At what eGFR thresholds should each be withheld, and what alternatives exist for glycaemic control in AKI?
Always review the OHA list before the creatinine result in a febrile diabetic. Metformin must be withheld at eGFR <30 (and proactively in any state of haemodynamic compromise). Glibenclamide is the most dangerous sulphonylurea in renal failure — its active metabolites accumulate causing prolonged, unpredictable hypoglycaemia.
Reflect: Should the ARB be withheld now, given this clinical trajectory? What principle guides this decision?
| Predisposing | DM2 (Glibenclamide + Metformin — both renally cleared; high AKI risk), HTN (on ARB+thiazide), poor dietary adherence |
| Symptoms | Biphasic pattern confirmed: early fever → apparent improvement → recurrent fatigue/myalgia at day 4–7 |
| Drug risks | Metformin (MALA risk in AKI), Glibenclamide (accumulation → hypoglycaemia), Telmisartan (worsens AKI via efferent arteriolar dilation), HCTZ (hyponatraemia risk) |
Stop. Unrefreshing sleep, spouse-reported snoring, and obesity in a hypertensive diabetic — what syndrome should you screen for, and how does its presence compound the metabolic risks already catalogued?
The absence of daytime somnolence does not exclude OSA. Many patients with OSA adapt to chronic sleep fragmentation and do not perceive excessive daytime sleepiness. Spouse-reported snoring + unrefreshing sleep + metabolic syndrome = strong OSA phenotype. Mallampati Class 3 (noted later) reinforces this.
The patient has occasional nocturia but denies frequency, urgency, or hesitancy. In this diabetic with possible renal disease, what are the three most likely explanations for nocturia, and how does each generate a different investigation priority?
In a 60-year-old diabetic male with hypertension, unrefreshing sleep, and snoring but without daytime somnolence, compare the STOP-BANG score utility versus overnight oximetry versus polysomnography for OSA screening. Also outline how untreated OSA worsens glycaemic control and cardiovascular risk.
Stop. He is a known hypertensive. His BP is 110/80. What does this tell you about his haemodynamic state, and what does it make you worry about?
Never interpret a BP in isolation — interpret it in context of the patient's baseline. A known hypertensive whose BP has "normalised" without anti-hypertensive dose change may in fact be in relative hypotension. Track the trend; assume haemodynamic stress until proven otherwise.
RBS is 664 mg/dL. Before ordering anything — what are the three immediate dangers of this glucose level, and what test pair would you urgently request to triage for the most life-threatening emergency?
Compare the diagnostic criteria, pathophysiology, and emergency management of Hyperosmolar Hyperglycaemic State (HHS) versus Diabetic Ketoacidosis (DKA) in a T2DM patient presenting with RBS 664 mg/dL. Include the corrected sodium formula and the role of infection as a precipitant.
RBS 664 + T2DM + no vomiting or altered sensorium + relative polyuria → think HHS first. HHS carries higher mortality than DKA and is frequently precipitated by infection. Corrected Na = [Na measured + 1.6 × ((glucose − 100) / 100)]. Markedly elevated corrected Na predicts profound free water deficit.
Before any IV fluids or insulin: you must decide which hyperglycaemic emergency this is, and in what order you act. What is your immediate management sequence in the first 30 minutes?
Think: Airway? Venous access? Which bloods first? Fluid bolus or cautious resuscitation? When does insulin come in?
RR is 22. In the context of everything we know — what are you thinking about, and how does it inform your urgency about the ABG?
| Signs (vitals) | Relative hypotension (110/80 in known hypertensive), tachycardia (93), afebrile (98.3°F — immune phase?), mild tachypnoea (RR 22), SpO₂ 97%, RBS 664 — hyperglycaemic emergency |
| Pathophysiology | Leptospira → systemic vasculitis + AKI → impaired glucose excretion → worsening hyperglycaemia; infection as HHS precipitant |
Stop. Subconjunctival haemorrhages + conjunctival suffusion + icterus in a farmer with rat-water exposure. This triad is almost diagnostic. What is it, and what does it tell you about disease severity?
Conjunctival suffusion is distinct from conjunctivitis. It is injection without discharge — the hallmark of leptospirosis ocular involvement. Combined with jaundice and haemorrhagic manifestations (subconjunctival bleeds) in the right epidemiological context, this is Weil's disease. Do not wait for serology to treat.
Terry nails — describe what you see and name at least three systemic conditions they indicate. Which one fits best in this patient's metabolic context?
Terry nails signal hypoalbuminaemia regardless of cause. The white opacification results from oedema of the nail bed displacing the vascular pattern. In this patient, both hepatocellular injury from leptospirosis AND protein loss from nephrotic/nephritic renal disease may be simultaneously depressing albumin.
Mallampati Class 3 is documented. Why is this clinically important in this patient — both for immediate management and longer-term risk?
Mallampati Class 3 predicts difficult intubation AND confirms an OSA-prone upper airway anatomy. In any febrile, hyperglycaemic patient who may require urgent intubation (e.g., for HHS-related neurological deterioration or pulmonary leptospirosis), a Class 3 airway must be flagged for the anaesthesia team early.
You now have: conjunctival suffusion + subconjunctival haemorrhages + icterus + pedal oedema + agricultural rat-water exposure. Would you start empirical antibiotic therapy NOW, before leptospira serology returns? What agent and dose?
In a patient with clinical Weil's disease (severe leptospirosis) presenting with jaundice, renal impairment, and haemorrhagic manifestations, compare IV Benzylpenicillin G versus IV Ceftriaxone as antibiotic choices — including evidence, dosing, and considerations in renal failure.
| Signs (exam) | Conjunctival suffusion (pathognomonic leptospirosis), subconjunctival haemorrhages, icterus, Terry nails (hypoalbuminaemia), Mallampati 3 (difficult airway / OSA anatomy), bilateral pitting oedema (40s pit resolution — moderate severity) |
| Severity | Weil's disease confirmed clinically — severe form. Multiorgan involvement: hepatic + renal + haemorrhagic |
Stop. The abdomen is distended but there is no organomegaly and no dilated veins. What explains abdominal distension without organomegaly or portal hypertensive signs in this patient?
Abdominal distension + soft, non-tender abdomen + no organomegaly + oedema + hypoalbuminaemia = ascites from low oncotic pressure until proven otherwise. Request bedside ultrasound. SAAG will guide aetiology — <1.1 g/dL favours hypoproteinaemia; >1.1 g/dL favours portal hypertension.
Respiratory exam is clear — bilateral air entry, no added sounds. Yet RR is 22. What extra-pulmonary causes of tachypnoea are you considering in this patient?
Tachypnoea without auscultatory signs can reflect metabolic acidosis (Kussmaul breathing), severe anaemia, pain, anxiety, or early interstitial lung disease not yet auscultable. In leptospirosis, pulmonary haemorrhage syndrome (ARDS-like) can begin before frank crackles appear. A CXR is non-negotiable.
No organomegaly detected on palpation. Does the absence of clinically palpable hepatosplenomegaly exclude hepatic involvement in leptospirosis? How should this influence your investigation strategy?
Stop. TB 3.2, DB 2.5, ALP 550. What pattern of liver injury does this represent — hepatocellular, cholestatic, or mixed? And how does this fit with leptospiral hepatitis?
Leptospiral jaundice is cholestatic, not hepatocellular. Unlike viral hepatitis where transaminases soar, in Weil's disease bilirubin is elevated (mostly direct) with relatively disproportionate ALP elevation and mildly elevated transaminases. The liver architecture is preserved — jaundice resolves with treatment. Massive hepatocellular failure is rare.
Urea 150, Creatinine 3.5. This is AKI. But there are 8–10 pus cells in urine. Does this change your thinking about the mechanism of AKI — pre-renal, intrinsic renal, or obstructive? And what specific renal lesion does leptospirosis cause?
Leptospiral AKI is characteristically non-oliguric tubulointerstitial nephritis. Patients may actually have polyuria despite significant renal impairment — a counter-intuitive finding that can delay recognition. Pyuria without bacteriuria on urine microscopy is a clue to interstitial nephritis. Prompt antibiotic therapy and fluid management can lead to full renal recovery.
Na 129, Cl 90. Hyponatraemia with hypochloraemia. List the mechanisms operating in this patient that could contribute to this pattern — at least three. Which is most likely dominant?
In a patient with Na 129 and glucose 664 mg/dL, calculate the corrected sodium. Then outline the differential diagnosis of hyponatraemia with hypochloraemia in the context of: Thiazide use, leptospiral tubulointerstitial nephritis, SIADH from infection, and hyperglycaemia-related pseudohyponatraemia. Which mechanism dominates, and how does management differ?
Always correct sodium for glucose before labelling hyponatraemia. For every 100 mg/dL rise in glucose above 100, Na falls ~1.6–2.4 mEq/L due to osmotic water shift. Corrected Na = 129 + 1.6 × (664−100)/100 ≈ 129 + 9 = ~138 mEq/L — potentially a near-normal corrected sodium, changing the entire electrolyte management approach.
The patient is on Telmisartan + HCTZ, Glibenclamide, and Metformin. He has AKI (Cr 3.5), hyponatraemia (Na 129), and RBS 664. Which drugs would you stop, which continue, and what would you substitute? Walk through your reasoning drug by drug.
| Investigations | RBS 664 (HHS, no ketosis), TB 3.2 / DB 2.5 / ALP 550 (cholestatic pattern), Urea 150 / Cr 3.5 (AKI — likely ATIN), Alb 2.9 (hypoalbuminaemia), Na 129 / Cl 90 (corrected Na ~138), Pyuria (8–10 WBC/hpf) without stated bacteriuria |
| Diagnosis | 1. Weil's disease (leptospirosis — ictero-haemorrhagic form) · 2. HHS (precipitated by infection) · 3. AKI — likely leptospiral ATIN ± HCTZ-ATIN · 4. Hyponatraemia (mixed: thiazide + pseudohyponatraemia) · 5. Hypoalbuminaemia · 6. Possible OSA |
| Treatment | IV Ceftriaxone 1g/day (adjust for AKI); IV fluids with careful osmolality monitoring; HOLD Metformin, Glibenclamide, HCTZ, Telmisartan; glucose management with insulin infusion; close renal monitoring |
| Epidemiology | 60-year-old male; agric-exposed farmer; barefoot in rat-infested water; tropical/subtropical; DM2 and HTN background |
| Predisposing conditions | DM2 (immunocompromised state, poor metabolic control, multiple OHAs); Hypertension (on ARB + thiazide); probable OSA (metabolic amplifier); poor dietary adherence; skin barrier compromise from agricultural work |
| Pathophysiology | Leptospira interrogans enter via skin abrasion/mucosa → haematogenous spread → systemic vasculitis → multiorgan involvement. Liver: intrahepatic cholestasis (not hepatocellular necrosis). Kidney: tubulointerstitial nephritis → non-oliguric AKI + tubular Na-wasting. Eye: conjunctival suffusion + subconjunctival haemorrhages. Haemostasis: thrombocytopaenia likely, haemorrhagic diathesis. Concurrent: infection precipitates HHS; thiazide + ATIN → hyponatraemia; ARB → worsens AKI |
| Symptoms | Biphasic: Week 1 — fever, malaise, anorexia → apparent improvement; Days 4–7 — fatigue, myalgia recur. Chief complaint: malaise, muscle aches, abdominal distension, anorexia, polyuria (non-oliguric AKI characteristic) |
| Signs | Relative hypotension (110/80 in hypertensive), tachycardia (93), tachypnoea (RR 22), conjunctival suffusion (pathognomonic), subconjunctival haemorrhages, icterus, Terry nails, Mallampati 3, bilateral pitting oedema, abdominal distension (likely ascites from hypoalbuminaemia) |
| Investigations | RBS 664 / no ketonuria → HHS. TB 3.2 / DB 2.5 / ALP 550 → cholestatic hepatitis. Urea 150 / Cr 3.5 → AKI stage 3 (KDIGO). Alb 2.9 → hypoalbuminaemia. Na 129 (corrected ~138) / Cl 90 → mixed hyponatraemia. Pyuria 8–10 WBC → interstitial nephritis. Serology: Microscopic Agglutination Test (MAT) — gold standard. IgM ELISA — rapid point-of-care |
| Complications | Pulmonary haemorrhage syndrome (ARDS-like — early warning: RR 22), severe AKI requiring RRT, haemorrhage, uveitis (late), hypoglycaemia from drug accumulation, cerebral oedema from HHS correction, MALA from Metformin |
| Treatment | IV Ceftriaxone 1g OD (preferred over Penicillin G in resource-limited setting; renal dose adjustment); IV 0.9% NaCl for HHS — target glucose fall ≤50 mg/dL/hour, osmolality fall ≤3 mOsm/kg/hr; IV Insulin infusion when glucose <300; HOLD Metformin (MALA risk), Glibenclamide (accumulation hypoglycaemia), HCTZ (worsens Na), Telmisartan (worsens AKI efferent arteriole); monitoring: hourly glucose, 4-hourly electrolytes, daily creatinine, urine output |
Commitment: Leptospirosis (Weil's disease) as the unifying diagnosis.
What would make this wrong? Consider: (1) Serology returns negative — MAT and IgM ELISA both negative in the right epidemiological window; would force reconsideration of other causes of ictero-haemorrhagic syndrome with AKI — malaria, dengue haemorrhagic fever, viral haemorrhagic fevers, Hantavirus, DILI. (2) Blood cultures grow an organism — bacteraemia from another source (gram-negative sepsis with multi-organ dysfunction). (3) The AKI worsens rapidly despite antibiotics and fluids — suggests a dominant non-leptospiral mechanism (DM nephropathy progression, contrast nephropathy, or obstructive uropathy missed on exam). (4) Bilirubin pattern on full LFTs shows high transaminases — would reconsider viral hepatitis (HBV/HCV with flare) or drug-induced liver injury (Metformin, Glibenclamide rarely). (5) Chest X-ray shows pulmonary infiltrates — could be aspiration, TB, or leptospiral pulmonary haemorrhage syndrome requiring escalation to ICU.